|
CH535201A
(de)
|
1969-12-19 |
1973-03-31 |
Bristol Myers Co |
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
|
|
JPS632932A
(ja)
|
1986-06-23 |
1988-01-07 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US4994467A
(en)
|
1989-05-31 |
1991-02-19 |
Zimmerman Andrew W |
Treating autism and other developmental disorders in children with NMDA receptor antagonists
|
|
DE4312016A1
(de)
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
US5543434A
(en)
|
1994-02-25 |
1996-08-06 |
Weg; Stuart L. |
Nasal administration of ketamine to manage pain
|
|
CA2213567C
(fr)
|
1995-02-24 |
2010-01-26 |
Stuart L. Weg |
Administration nasale et oculaire de ketamine pour soulager la douleur ou assurer une desintoxication
|
|
WO1997007750A1
(fr)
|
1995-08-30 |
1997-03-06 |
Weg Stuart L |
Administration de ketamine pour gerer la douleur et reduire la dependance aux medicaments
|
|
FR2739294B1
(fr)
|
1995-09-29 |
1998-01-16 |
Lhd Lab Hygiene Dietetique |
Embout nasal de securite
|
|
DE19619665C2
(de)
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
DE19723133A1
(de)
|
1997-06-03 |
1998-12-10 |
Caideil M P Teoranta Tourmakea |
Austragvorrichtung für Medien
|
|
FR2764807B1
(fr)
|
1997-06-18 |
1999-08-20 |
Valois Sa |
Dispositif de distribution nasale d'un produit fluide ou pulverulent
|
|
RU2224523C2
(ru)
|
1998-07-24 |
2004-02-27 |
Сео Хонг Ю |
Водный раствор, содержащий желчную кислоту, и способ его получения
|
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
|
US6017961A
(en)
|
1999-07-08 |
2000-01-25 |
Flores; John Anthony |
Ketamine and n-butyl-p-aminobezoate in PLO
|
|
EP1103256A1
(fr)
|
1999-11-26 |
2001-05-30 |
Claudius Dr. med. Böck |
Utilisation de la kétamine pour le traitement de la dysfonction immunitaire neuroendocrine et du psyhosyndrome algogénique
|
|
CA2423354C
(fr)
|
2000-09-20 |
2009-12-15 |
Lee Shahinian Jr. |
Preparations et medications nasales, inhalables et ophtalmiques locales a conservation spontanee
|
|
US6881731B1
(en)
|
2000-10-23 |
2005-04-19 |
Shanbrom Technologies, Llc |
Enhancers for microbiological disinfection
|
|
EP1551393A4
(fr)
|
2002-07-30 |
2010-06-16 |
Peter Migaly |
Combinaison de therapie pour la depression, la prevention du suicide et divers troubles medicaux et psychiatriques
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
CA2506615A1
(fr)
|
2002-11-18 |
2004-06-03 |
Yaupon Therapeutics, Inc. |
Utilisations analgesiques de norketamine et de promedicaments de ketamine/norketamine
|
|
US7687080B2
(en)
|
2002-11-25 |
2010-03-30 |
Taraxos Inc. |
Treatment of neuropathy
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US8082173B2
(en)
*
|
2003-05-22 |
2011-12-20 |
Cecil Kost |
Drug sample fulfillment architecture
|
|
US20050095277A1
(en)
|
2003-06-25 |
2005-05-05 |
Binnur Ozturk |
Neuropathy cream
|
|
US20040265364A1
(en)
|
2003-06-25 |
2004-12-30 |
Binnur Ozturk |
Neuropathy cream
|
|
EP1734920A2
(fr)
|
2004-02-13 |
2006-12-27 |
Neuromolecular Inc. |
Combinaison d'un antagoniste du recepteur nmda et d'un inhibiteur mao ou gadpf pour le traitement des troubles psychiatriques
|
|
DK2486942T3
(en)
|
2004-11-24 |
2019-01-28 |
Meda Pharmaceuticals Inc |
COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
|
|
US20060223788A1
(en)
|
2005-03-29 |
2006-10-05 |
Cathcart Clifton H |
Analgesic composition for topical use
|
|
WO2006130098A1
(fr)
|
2005-06-01 |
2006-12-07 |
Shl Medical Ab |
Administrateur de doses posologiques
|
|
US20060276550A1
(en)
|
2005-06-03 |
2006-12-07 |
Dileep Bhagwat |
Topical compositions of ketamine and butamben and methods of their use
|
|
CN101466364A
(zh)
|
2006-03-22 |
2009-06-24 |
纽约大学西奈山医学院 |
鼻内施用氯胺酮治疗抑郁症
|
|
US20070256688A1
(en)
|
2006-04-21 |
2007-11-08 |
Aradigm Corporation |
Mechanical single dose intrapulmonary drug delivery devices
|
|
US20090306137A1
(en)
|
2006-05-22 |
2009-12-10 |
Wolfgang Curt D |
Treatment for depressive disorders
|
|
DE102007009888A1
(de)
|
2007-02-28 |
2008-09-04 |
Hermann, Holger Lars, Dr. |
Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
|
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
|
US7745665B2
(en)
*
|
2007-06-04 |
2010-06-29 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
US8710070B2
(en)
|
2008-03-27 |
2014-04-29 |
University Of Kentucky Research Foundation |
Opioid-ketamine and norketamine codrug combinations for pain management
|
|
CA2724277A1
(fr)
|
2008-05-13 |
2009-11-19 |
Clarassance, Inc. |
Proteine recombinee humaine cc10 et compositions la contenant pour le traitement de la rhinite nasale
|
|
US20110038807A1
(en)
|
2009-08-14 |
2011-02-17 |
Demitri Papolos |
Compositions and methods for treating bipolar disorder
|
|
US20120225949A1
(en)
|
2009-08-14 |
2012-09-06 |
Demitri Papalos |
Compositions and methods for treating bipolar disorder
|
|
RU2589692C2
(ru)
|
2010-06-15 |
2016-07-10 |
Грюненталь Гмбх |
Фармацевтическая комбинация для лечения от боли
|
|
US9073819B2
(en)
|
2011-06-30 |
2015-07-07 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
CN104395283A
(zh)
|
2011-10-14 |
2015-03-04 |
美国政府健康及人类服务部 |
(2r,6r)-羟基去甲氯胺酮、(s)-脱氢去甲氯胺酮以及(r,s)-氯胺酮的其他立体异构脱氢和羟基化代谢物在治疗忧郁症和神经性疼痛中的应用
|
|
KR102035877B1
(ko)
|
2011-11-14 |
2019-10-23 |
알파시그마 에스.피.에이. |
우울증이 있는 대상체를 위한 치료 양생법 선택을 위한 검정법 및 치료 방법
|
|
US20130209585A1
(en)
|
2012-02-13 |
2013-08-15 |
Stanley Kim |
Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
|
|
WO2013138322A1
(fr)
*
|
2012-03-12 |
2013-09-19 |
Janssen Pharmaceutica Nv |
Eskétamine dans le traitement de la dépression réfractaire ou résistante aux traitements
|
|
AU2016203771A1
(en)
|
2012-03-13 |
2016-06-23 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
JP2015512418A
(ja)
|
2012-03-30 |
2015-04-27 |
ザ ジェネラル ホスピタル コーポレイション |
うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
|
|
WO2014020155A1
(fr)
|
2012-08-02 |
2014-02-06 |
Clinpharm Reform Gmbh |
Formes d'administration transmuqueuse orale de kétamine s
|
|
AU2013305580A1
(en)
|
2012-08-23 |
2015-04-09 |
Stuart L. Weg |
Anxiolytic composition, formulation and method of use
|
|
FR2994844B1
(fr)
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
NZ619257A
(en)
|
2012-10-08 |
2015-07-31 |
Auckland Uniservices Ltd |
Ketamine derivatives
|
|
ES2484068B1
(es)
|
2013-02-08 |
2015-04-16 |
Ana MÍNGUEZ MARTÍ |
Una composición farmacéutica que contiene ketamina y amitriptilina
|
|
US20140275278A1
(en)
|
2013-03-15 |
2014-09-18 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition of s-ketamine hydrochloride
|
|
AU2014250756B2
(en)
|
2013-04-12 |
2019-03-07 |
Icahn School Of Medicine At Mount Sinai |
Method for treating post-traumatic stress disorder
|
|
WO2015031410A1
(fr)
|
2013-08-26 |
2015-03-05 |
Amorsa Therapeutics, Inc. |
Dose orale à couche unique de kétamine neuro-atténuante
|
|
HRP20211629T1
(hr)
|
2013-09-13 |
2022-02-04 |
National University Corporation Chiba University |
Primjena r-ketamina i njegove soli kao lijekova
|
|
CN103705909A
(zh)
|
2013-12-16 |
2014-04-09 |
陈镜伊 |
一种无痛人流用药
|
|
WO2015101693A1
(fr)
|
2013-12-31 |
2015-07-09 |
Servicio Andaluz De Salud |
Compositions et préparations combinées pour le traitement des douleurs oropharyngées
|
|
CA2936809A1
(fr)
|
2014-01-14 |
2015-07-23 |
Children's Hospital Medical Center |
Compositions comprenant de la ketamine pour le traitement d'un trouble du spectre de l'autisme
|
|
EP3287124B1
(fr)
|
2014-04-17 |
2022-11-30 |
Ketabon GmbH |
Forme posologique orale de kétamine
|
|
ES2702330T3
(es)
|
2014-05-04 |
2019-02-28 |
Firmenich & Cie |
Alimentos y bebidas aromatizados
|
|
FR3023188B1
(fr)
|
2014-07-04 |
2016-08-19 |
Aptar France Sas |
Dispositif de distribution de produit fluide.
|
|
EP3179993B1
(fr)
|
2014-08-13 |
2021-01-20 |
Janssen Pharmaceutica NV |
Esketamine pour son utilisation dans une méthode de traitement de la dépression
|
|
CA2961208A1
(fr)
*
|
2014-09-15 |
2016-03-24 |
Janssen Pharmaceutica Nv |
Regimes posologiques specifiques au genotype val66met (snp rs6265) et methodes pour le traitement de la depression
|
|
US20180015054A1
(en)
|
2014-12-31 |
2018-01-18 |
Icahn School Of Medicine At Mount Sinai |
Method of Maintaining the Anti-Depressant Effect of Ketamine With Lithium
|
|
WO2016172672A1
(fr)
|
2015-04-24 |
2016-10-27 |
Icahn School Of Medicine At Mount Sinai |
Procédé de traitement d'idéation suicidaire
|
|
CN104798728A
(zh)
|
2015-05-08 |
2015-07-29 |
南京中医药大学 |
产后抑郁动物模型的建立方法及其应用
|
|
US20160332962A1
(en)
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20160338977A1
(en)
*
|
2015-05-20 |
2016-11-24 |
Janssen Pharmaceutica Nv |
Methods and kits for treating depression
|
|
AU2016288188B2
(en)
|
2015-06-27 |
2021-08-05 |
Shenox Pharmaceuticals, Llc |
Ketamine transdermal delivery system
|
|
US20180296478A1
(en)
|
2016-02-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Sublingual antidepressant and antianxiety tablet
|
|
US20180042936A1
(en)
|
2016-03-18 |
2018-02-15 |
Genomind, Inc. |
Maintenance therapy using tianeptine
|
|
MX2020006650A
(es)
*
|
2017-12-22 |
2020-11-06 |
Janssen Pharmaceuticals Inc |
Esketamina para el tratamiento de la depresión.
|
|
WO2020178653A1
(fr)
*
|
2019-03-05 |
2020-09-10 |
Janssen Pharmaceuticals, Inc. |
Eskétamine pour le traitement de la dépression
|